McCormick said in a press conference Thursday that he was concerned nitazenes “would become the next fentanyl,” the opioid behind a massive rise in overdose deaths across the U.S.
Cannabis may be on its way to being less restricted in the U.S. after a recent recommendation from the Health and Human Services Department to reschedule the drug's classification. Last week, the HHS ...
The Nevada Board of Pharmacy’s classification of cannabis as a Schedule 1 drug is unconstitutional, a district judge ruled Wednesday. The ruling came in a lawsuit filed against the Board of Pharmacy ...
The Nevada Supreme Court will allow the state Board of Pharmacy to continue classifying marijuana as a Schedule I drug on par with heroin, in a reversal of a district judge’s previous ruling. The ...
World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure ...
The FDA says more than 580,000 bottles of a blood pressure medication have been recalled over concerns that it may contain a ...
More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...